BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10807003)

  • 1. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Mignet N; Gryaznov SM
    Nucleic Acids Res; 1998 Jan; 26(2):431-8. PubMed ID: 9421496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic oligonucleotides as RNA mimetics: 2'-modified Rnas and N3'-->P5' phosphoramidates.
    Egli M; Gryaznov SM
    Cell Mol Life Sci; 2000 Sep; 57(10):1440-56. PubMed ID: 11078022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Oligonucleotide 2'-O-Alkyl N3'→P5' (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity.
    Martínez-Montero S; Rajwanshi VK; Pandey RK; De Costa NTS; Hong J; Beigelman L; Gryaznov SM; Pourshahian S
    Nucleic Acid Ther; 2023 Oct; 33(5):319-328. PubMed ID: 37638793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and properties of 3'-amino-2',4'-BNA, a bridged nucleic acid with a N3'-->P5' phosphoramidate linkage.
    Obika S; Rahman SM; Song B; Onoda M; Koizumi M; Morita K; Imanishi T
    Bioorg Med Chem; 2008 Oct; 16(20):9230-7. PubMed ID: 18812260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL-6 in mice by anti-NF-kappaB oligodeoxyribonucleotide N3'-->oligodeoxyribonnucleotide N3' --> P5' phosphoramidates.
    Wang L; Gryaznov S; Nerenberg M
    Inflammation; 1999 Dec; 23(6):583-90. PubMed ID: 10565571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.
    Heidenreich O; Gryaznov S; Nerenberg M
    Nucleic Acids Res; 1997 Feb; 25(4):776-80. PubMed ID: 9016628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo.
    Skorski T; Perrotti D; Nieborowska-Skorska M; Gryaznov S; Calabretta B
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3966-71. PubMed ID: 9108088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection of oligonucleotide N3'-->P5' phosphoramidate/RNA duplexes with capillary gel electrophoresis.
    DeDionisio L; Raible AM; Gryaznov SM
    Electrophoresis; 1998 Jun; 19(8-9):1265-9. PubMed ID: 9694262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'-amino-2',4'-BNA: novel bridged nucleic acids having an N3'-->P5' phosphoramidate linkage.
    Obika S; Onoda M; Morita K; Andoh J; Koizumi M; Imanishi T
    Chem Commun (Camb); 2001 Oct; (19):1992-3. PubMed ID: 12240255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.